Washington, Sept 26 : According to a study focused on non-mass enhancing breast lesions, Proton magnetic resonance spectroscopy (¹H MRS) used in conjunction with magnetic resonance imaging (MRI) can aid radiologists in diagnosing breast cancer while reducing the number of false-positive results and invasive biopsies.
The study, conducted at Memorial Sloan-Kettering Cancer Centre in New York, is published in the October issue of the journal Radiology.